14 studies found for:    lymphoseek
Show Display Options
Rank Status Study
1 Recruiting Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Lymphoseek;   Drug: Sulfur Colloid
2 Completed
Has Results
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
Conditions: Breast Cancer;   Melanoma
Intervention: Drug: Lymphoseek
3 Recruiting Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
Condition: Endometrial Cancer
Intervention: Drug: Lymphoseek plus Vital Blue Dye
4 Completed
Has Results
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Conditions: Breast Cancer;   Melanoma
Intervention: Drug: Lymphoseek
5 Not yet recruiting A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
Condition: Anal Cancer
Intervention: Drug: Lymphoseek
6 Recruiting A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
Condition: Uterine Cervical Neoplasms
Intervention: Drug: Tc99m tilmanocept
7 Active, not recruiting Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)
Conditions: Colon Cancer;   Rectal Cancer
Intervention: Drug: Lymphoseek and VBD Sln dissection
8 Recruiting A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Conditions: Rhabdomyosarcoma;   Melanoma
Interventions: Drug: Tc99m tilmanocept;   Drug: Vital Blue Dye
9 Terminated
Has Results
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
Intervention: Drug: Lymphoseek
10 Enrolling by invitation Use of 99mTc Tilmanocept for Imaging Arterial Inflammation
Condition: HIV
Intervention: Other: Arterial Imaging
11 Completed Evaluation of Technetium Tc 99m Tilmanocept (Lymphoseek®) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage From KS Lesions by SPECT and SPECT/CT Imaging
Condition: Kaposi's Sarcoma
Intervention: Drug: Tc 99m tilmanocept
12 Recruiting Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging
Condition: Rheumatoid Arthritis
Intervention: Drug: tilmanocept
13 Completed Sentinel Lymph Node Mapping Post-Injection Site Pain
Condition: Breast Cancer
Interventions: Drug: Tilmanocept;   Drug: Sulfur Colloid
14 Recruiting Targeted Silica Nanoparticles for Image-Guided Intraoperative Sentinel Lymph Node Mapping in Head and Neck Melanoma, Breast and Cervical/Uterine Cancer Patients
Conditions: Head and Neck Cancer;   Melanoma;   Breast Cancer;   Cervical Cancer;   Uterine Cancer
Intervention: Drug: fluorescent cRGDY-PEG-Cy5.5-C dots

Indicates status has not been verified in more than two years